Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 454

1.

Mediastinal lymph node uptake in patients with prostate carcinoma on F18-choline PET/CT.

Rietbergen DD, van der Hiel B, Vogel W, Stokkel MP.

Nucl Med Commun. 2011 Dec;32(12):1143-7. doi: 10.1097/MNM.0b013e32834b76fa.

PMID:
22045476
2.

[18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.

Poulsen MH, Bouchelouche K, Høilund-Carlsen PF, Petersen H, Gerke O, Steffansen SI, Marcussen N, Svolgaard N, Vach W, Geertsen U, Walter S.

BJU Int. 2012 Dec;110(11):1666-71. doi: 10.1111/j.1464-410X.2012.11150.x. Epub 2012 Apr 23.

3.

Clinical utility of (18)F-fluorocholine positron-emission tomography/computed tomography (PET/CT) in biochemical relapse of prostate cancer after radical treatment: results of a multicentre study.

Rodado-Marina S, Coronado-Poggio M, García-Vicente AM, García-Garzón JR, Alonso-Farto JC, de la Jara AC, Maldonado-Suárez A, Rodríguez-Fernández A.

BJU Int. 2015 Jun;115(6):874-83. doi: 10.1111/bju.12953. Epub 2015 Jan 21.

4.

18F-choline and/or 11C-acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate-specific antigen values (<1 ng/mL) after radical prostatectomy.

Vees H, Buchegger F, Albrecht S, Khan H, Husarik D, Zaidi H, Soloviev D, Hany TF, Miralbell R.

BJU Int. 2007 Jun;99(6):1415-20. Epub 2007 Apr 8.

5.

Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer.

Schilling D, Schlemmer HP, Wagner PH, Böttcher P, Merseburger AS, Aschoff P, Bares R, Pfannenberg C, Ganswindt U, Corvin S, Stenzl A.

BJU Int. 2008 Aug;102(4):446-51. doi: 10.1111/j.1464-410X.2008.07592.x. Epub 2008 Apr 11.

6.

[PET/CT with (11)C-choline and (18)F-FDG in patients with elevated PSA after radical treatment of a prostate cancer].

García JR, Soler M, Blanch MA, Ramírez I, Riera E, Lozano P, Pérez X, Delgado E, Carrio I, Lomeña F.

Rev Esp Med Nucl. 2009 May-Jun;28(3):95-100. Spanish.

7.

Impact of ¹⁸F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma.

Ozkan E, Soydal C, Kucuk ON, Ibis E, Erbay G.

Nucl Med Commun. 2011 Dec;32(12):1162-8. doi: 10.1097/MNM.0b013e32834bbe09.

PMID:
21946617
8.

Is there a role for ¹¹C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng/ml?

Castellucci P, Fuccio C, Rubello D, Schiavina R, Santi I, Nanni C, Allegri V, Montini GC, Ambrosini V, Boschi S, Martorana G, Marzola MC, Fanti S.

Eur J Nucl Med Mol Imaging. 2011 Jan;38(1):55-63. doi: 10.1007/s00259-010-1604-0. Epub 2010 Sep 17.

PMID:
20848281
10.

Contribution of 11C-Choline PET/CT in prostate carcinoma biochemical relapse with serum PSA level below 1 ng/ml.

Gómez-de la Fuente FJ, Martínez-Rodríguez I, de Arcocha-Torres M, Quirce R, Jiménez-Bonilla J, Martínez-Amador N, Banzo I.

Rev Esp Med Nucl Imagen Mol. 2018 May - Jun;37(3):156-162. doi: 10.1016/j.remn.2017.10.001. Epub 2017 Nov 12. English, Spanish.

PMID:
29137875
11.

18F-Fluoroethylcholine PET/CT identifies lymph node metastasis in patients with prostate-specific antigen failure after radical prostatectomy but underestimates its extent.

Tilki D, Reich O, Graser A, Hacker M, Silchinger J, Becker AJ, Khoder W, Bartenstein P, Stief CG, Loidl W, Seitz M.

Eur Urol. 2013 May;63(5):792-6. doi: 10.1016/j.eururo.2012.08.003. Epub 2012 Aug 10.

PMID:
22902037
12.

Pelvic/retroperitoneal salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence and nodal recurrence detected by [11C]choline positron emission tomography/computed tomography.

Rigatti P, Suardi N, Briganti A, Da Pozzo LF, Tutolo M, Villa L, Gallina A, Capitanio U, Abdollah F, Scattoni V, Colombo R, Freschi M, Picchio M, Messa C, Guazzoni G, Montorsi F.

Eur Urol. 2011 Nov;60(5):935-43. doi: 10.1016/j.eururo.2011.07.060. Epub 2011 Aug 3.

PMID:
21840116
13.

Impact of 18F-choline PET/CT in prostate cancer patients with biochemical recurrence: influence of androgen deprivation therapy and correlation with PSA kinetics.

Beheshti M, Haim S, Zakavi R, Steinmair M, Waldenberger P, Kunit T, Nader M, Langsteger W, Loidl W.

J Nucl Med. 2013 Jun;54(6):833-40. doi: 10.2967/jnumed.112.110148. Epub 2013 Apr 4.

14.

(18)F-choline PET/CT for early detection of metastases in biochemical recurrence following radical prostatectomy.

Kjölhede H, Ahlgren G, Almquist H, Liedberg F, Lyttkens K, Ohlsson T, Bratt O.

World J Urol. 2015 Nov;33(11):1749-52. doi: 10.1007/s00345-015-1547-y. Epub 2015 Apr 1.

PMID:
25824540
15.

11C-choline PET/CT detects the site of relapse in the majority of prostate cancer patients showing biochemical recurrence after EBRT.

Ceci F, Castellucci P, Graziani T, Schiavina R, Brunocilla E, Mazzarotto R, Ntreta M, Lodi F, Martorana G, Fanti S.

Eur J Nucl Med Mol Imaging. 2014 May;41(5):878-86. doi: 10.1007/s00259-013-2655-9. Epub 2013 Dec 18.

PMID:
24346416
16.

Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure?

Goldstein J, Even-Sapir E, Ben-Haim S, Saad A, Spieler B, Davidson T, Berger R, Weiss I, Appel S, Lawrence YR, Symon Z.

Am J Clin Oncol. 2017 Jun;40(3):256-259. doi: 10.1097/COC.0000000000000139.

PMID:
25319322
17.

Pattern of occult nodal relapse diagnosed with (18)F-fluoro-choline PET/CT in prostate cancer patients with biochemical failure after prostate-only radiotherapy.

Lépinoy A, Cochet A, Cueff A, Cormier L, Martin E, Maingon P, Bosset JF, Brunotte F, Créhange G.

Radiother Oncol. 2014 Apr;111(1):120-5. doi: 10.1016/j.radonc.2014.03.008. Epub 2014 Apr 26.

PMID:
24780635
18.

First results of [11C]choline PET/CT-guided secondary lymph node surgery in patients with PSA failure and single lymph node recurrence after radical retropubic prostatectomy.

Winter A, Uphoff J, Henke RP, Wawroschek F.

Urol Int. 2010;84(4):418-23. doi: 10.1159/000296298. Epub 2010 Mar 17.

PMID:
20299773
19.

Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy.

Scattoni V, Picchio M, Suardi N, Messa C, Freschi M, Roscigno M, Da Pozzo L, Bocciardi A, Rigatti P, Fazio F.

Eur Urol. 2007 Aug;52(2):423-9. Epub 2007 Mar 20.

PMID:
17397992
20.

[11C]Choline PET/CT for targeted salvage lymph node dissection in patients with biochemical recurrence after primary curative therapy for prostate cancer. Preliminary results of a prospective study.

Rinnab L, Mottaghy FM, Simon J, Volkmer BG, de Petriconi R, Hautmann RE, Wittbrodt M, Egghart G, Moeller P, Blumstein N, Reske S, Kuefer R.

Urol Int. 2008;81(2):191-7. doi: 10.1159/000144059. Epub 2008 Aug 29.

PMID:
18758218

Supplemental Content

Support Center